Evidence map›Paper›PMID 36197920›Full record

ArticleJournal of viral hepatitis2023

More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study.

Moonseong Heo, Irene Pericot-Valverde, Jiajing Niu, Brianna L Norton, Matthew J Akiyama, Shadi Nahvi, Julia H Arnsten, Alain H Litwin

Open access · hybridAbstract read
In one paragraph

Article in Journal of viral hepatitis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Moonseong HeoDepartment of Public Health Sciences, Clemson University, Clemson, South Carolina, USA.ORCID 0000-0001-7711-1209
Irene Pericot-ValverdeDepartment of Psychology, Clemson University, Clemson, South Carolina, USA.
Jiajing NiuSchool of Mathematical and Statistical Sciences, Clemson University, Clemson, South Carolina, USA.
Brianna L NortonDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.ORCID 0000-0002-8287-2245
Matthew J AkiyamaDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.ORCID 0000-0003-4290-3083
Shadi NahviDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
Julia H ArnstenDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
Alain H LitwinDepartment of Medicine, University of South Carolina School of Medicine, Greenville, South Carolina, USA.ORCID 0000-0002-6717-0288
Albert Einstein College of Medicine · USClemson University · USPrisma Health · US

Funding

CTSA Administrative Supplement for Informatics Core: A novel AI/ML system to predict respiratory failure and ARDS in Covid-19 patientsUL1TR002556 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, KIM, MIMI Y · 2018 to 2022
$26.7M
Intensive Models of HCV Care for Injection Drug UsersR01DA034086 · NIDA · CLEMSON UNIVERSITY · PI LITWIN, ALAIN HARRIS · 2012 to 2016
$3.7M
Mentoring investigators to improve health outcomes among persons with opioid and tobacco use disorderK24DA051807 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Shadi Nahvi · 2022 to 2026
$972k
Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants LivingR00DA043011 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI AKIYAMA, MATTHEW · 2020 to 2022
$747k
Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants Living with Hepatitis C-The HCV-ACCELERATE TrialK99DA043011 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI AKIYAMA, MATTHEW · 2017 to 2018
$369k
NCATS NIH HHS UL1 TR002556NIDA NIH HHS K24 DA051807NIDA NIH HHS K99 DA043011NIDA NIH HHS R00 DA043011NIDA NIH HHS R01 DA034086
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug UsersHepatitis CHepatitis C, ChronicSubstance Abuse, IntravenousSubstance-Related DisordersAntiviral AgentsHepacivirusHumansAntiviral AgentsadherenceDAAdrug useHCVPWID

Identifiers

PMID36197920
PMCPMC9851956
OpenAlexW4302011910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.